Natco Pharma gets USFDA approval for Visakhapatnam facility

Hyderabad-based Natco Pharma Ltd on Tuesday said it has received the
final approval from the US health regulator for its first supplemental
abbreviated new drug application (sANDA) filed from its new drug
formulations facility at Visakhapatnam, Andhra Pradesh.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-gets-usfda-approval-for-visakhapatnam-facility/articleshow/75423966.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment